Company page
Tibet Rhodiola Pharmaceutical Holding Co. Class A
Tibet Rhodiola Pharmaceutical Holding Co. Class A, traded under the ticker 600211, operates in the Chinese market. The company has a market capitalization of approximately 1.83 billion USD. Tibet Rhodiola focuses on the development and production of traditional herbal medicines, particularly those derived from the Rhodiola plant.
- Ticker
- 600211:SSE
- Asset type
- Stock
- Market cap
- $1.83B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- SSE
- Currency
- CNY